We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Patent Deal Is No Sham, Tribe Tells PTAB

Law360, New York (October 23, 2017, 10:00 PM EDT) -- A Native American tribe that acquired patents for Allergan’s blockbuster eye drug Restasis is sharply criticizing generic-drug makers for questioning its sovereign immunity from Patent Trial and Appeal Board proceedings, saying...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.